ClinicalTrials.govpublic full text
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
her2/neu positive, recurrent breast carcinoma, stage iv breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 195315
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.